Adaptation to TKI Treatment Reactivates ERK Signaling in Tyrosine Kinase-Driven Leukemias and Other Malignancies.
about
Crosstalk between VEGFR and other receptor tyrosine kinases for TKI therapy of metastatic renal cell carcinoma.Sorafenib Dose Recommendation in Acute Myeloid Leukemia Based on Exposure-FLT3 Relationship.Early changes in rpS6 phosphorylation and BH3 profiling predict response to chemotherapy in AML cells.Combination of ATO with FLT3 TKIs eliminates FLT3/ITD+ leukemia cells through reduced expression of FLT3
P2860
Adaptation to TKI Treatment Reactivates ERK Signaling in Tyrosine Kinase-Driven Leukemias and Other Malignancies.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Adaptation to TKI Treatment Re ...... kemias and Other Malignancies.
@en
Adaptation to TKI Treatment Re ...... kemias and Other Malignancies.
@nl
type
label
Adaptation to TKI Treatment Re ...... kemias and Other Malignancies.
@en
Adaptation to TKI Treatment Re ...... kemias and Other Malignancies.
@nl
prefLabel
Adaptation to TKI Treatment Re ...... kemias and Other Malignancies.
@en
Adaptation to TKI Treatment Re ...... kemias and Other Malignancies.
@nl
P2093
P2860
P1433
P1476
Adaptation to TKI Treatment Re ...... kemias and Other Malignancies.
@en
P2093
Alice Can Ran Qin
Christine A Pratilas
Donald Small
Hayley S Ma
J Kyle Bruner
Keith W Pratz
Mark J Levis
Michelle A Rudek
Richard J Jones
P2860
P304
P356
10.1158/0008-5472.CAN-16-2593
P407
P577
2017-09-18T00:00:00Z